{{Rsnum
|rsid=2746073
|Gene=RGS2
|Chromosome=1
|position=192810097
|Orientation=plus
|GMAF=0.2668
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=RGS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 9.5 | 27.0 | 63.5
| HCB | 15.6 | 60.0 | 24.4
| JPT | 9.8 | 53.7 | 36.6
| YRI | 1.6 | 18.0 | 80.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 15.6 | 60.0 | 24.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=18347610
|Title=Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region
}}

{{PMID|18262772|OA=1
}} Association of RGS2 and RGS5 variants with schizophrenia symptom severity.

{{PMID|20386734|OA=1
}} Further evidence supporting a role for gs signal transduction in severe malaria pathogenesis.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}